MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of 0.05percommonshare,payableinCanadianDollarsonJune13,2025,toshareholdersofrecordatthecloseofbusinessonMay30,2025.Thissecondquarter2025dividendcompareswiththefirstquarter2025dividendof0.05 per common share. This dividend qualifies as an 'eligible dividend' for Canadian in ...